Eberconazole
Alternative Names: Eberconazol; Eberconazole nitrate; Ebernet; WAS 2160Latest Information Update: 08 Nov 2010
Price :
$50 *
At a glance
- Originator Chiesi Wassermann
- Developer Chiesi Wassermann; SALVAT
- Class Antifungals; Cycloheptanes; Imidazoles; Small molecules
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Marketed Mycoses; Tinea
Most Recent Events
- 05 Sep 2007 Launched for Mycoses in India (Topical)
- 05 Sep 2007 Launched for Tinea in India (Topical)
- 31 Dec 2006 Eberconazole is available for licensing in European countries other than Spain (http://www.salvat-lab.es)